Pay in 4 interest-free payments of $6.84 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Products or therapies discussed may not be registered or approved in all jurisdictions, including Singapore
In seeking to identify existing drugs with anti-fibrotic potential that could be repurposed, incretin receptor agonists, namely the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists, are emerging as candidates
"Weight alone is not a health issue," Richmond said
Targeting lipid GPCRs to treat type 2 diabetes mellitus - progress and challenges
US$ 24.49
US$ 22.68
US$ 27.03
US$ 20.65
US$ 21.67
US$ 23.06
US$ 28.03
US$ 21.33
US$ 29.80
